Cargando…

A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes

BACKGROUND: The EQ-5D is frequently used to derive utilities for patients with type 2 diabetes (T2D). Despite widely available quantitative psychometric data on the EQ-5D, little is known about content validity in this population. Thus, the purpose of this qualitative study was to examine content va...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matza, Louis S., Boye, Kristina S., Stewart, Katie D., Curtis, Bradley H., Reaney, Matthew, Landrian, Amanda S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665831/ https://www.ncbi.nlm.nih.gov/pubmed/26627874 http://dx.doi.org/10.1186/s12955-015-0373-7

Ejemplares similares

Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)
por: Matza, Louis S., et al.
Publicado: (2018)

Psychometric evaluation of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)
por: Matza, Louis S., et al.
Publicado: (2018)

A Qualitative Assessment of the Content Validity of the ICECAP-A and EQ-5D-5L and Their Appropriateness for Use in Health Research
por: Keeley, Thomas, et al.
Publicado: (2013)

Validity of EQ-5D-5L in stroke
por: Golicki, Dominik, et al.
Publicado: (2014)

Exit Interviews Examining the Patient Experience in Clinical Trials of Tirzepatide for Treatment of Type 2 Diabetes
por: Matza, Louis S., et al.
Publicado: (2022)

EQ-5D: a plea for accurate nomenclature
por: Brooks, Richard, et al.
Publicado: (2020)

Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type 2 Diabetes
por: Boye, Kristina S., et al.
Publicado: (2023)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

German Value Set for the EQ-5D-5L
por: Ludwig, Kristina, et al.
Publicado: (2018)

Population norms for the EQ-5D-3L and EQ-5D-5L in Romania
por: Olariu, Elena, et al.
Publicado: (2023)

Mapping between EQ‐5D‐3L and EQ‐5D‐5L: A survey experiment on the validity of multi‐instrument data
por: Hernández‐Alava, Mónica, et al.
Publicado: (2022)

How do EQ-5D-3L and EQ-5D-5L compare in a Swedish total hip replacement population?
por: Eneqvist, Ted, et al.
Publicado: (2020)

Development of a patient-reported outcome (PRO) measure to assess patient perceptions of simplicity and complexity of treatment for type 2 diabetes
por: Stewart, Katie D., et al.
Publicado: (2023)

EQ-5D-Y-5L: developing a revised EQ-5D-Y with increased response categories
por: Kreimeier, Simone, et al.
Publicado: (2019)

Validation of two generic patient-reported outcome measures in patients with type 2 diabetes
por: Matza, Louis S, et al.
Publicado: (2007)

A French Value Set for the EQ-5D-5L
por: Andrade, Luiz Flavio, et al.
Publicado: (2020)

Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults
por: Ferreira, Lara N., et al.
Publicado: (2016)

Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values
por: Selivanova, Anna, et al.
Publicado: (2018)

Comparing the performance of the EQ-5D-3 L and the EQ-5D-5 L in an elderly Chinese population
por: You, Ruxu, et al.
Publicado: (2020)

Exploration of the content validity and feasibility of the EQ-5D-3L, ICECAP-O and ASCOT in older adults
por: van Leeuwen, Karen M, et al.
Publicado: (2015)

Validity and reliability of the EQ-5D-5 L in family caregivers of leukemia patients
por: Li, Limin, et al.
Publicado: (2019)

Validity of the EQ-5D-5L questionnaire among the general population of Poland
por: Młyńczak, Katarzyna, et al.
Publicado: (2020)

Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD)
por: Matza, Louis S., et al.
Publicado: (2023)

Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care
por: Verstraete, Janine, et al.
Publicado: (2022)

Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients
por: Pattanaphesaj, Juntana, et al.
Publicado: (2015)

Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
por: Mulhern, Brendan, et al.
Publicado: (2018)

The measurement performance of the EQ-5D-5L versus EQ-5D-3L in patients with hidradenitis suppurativa
por: Bató, Alex, et al.
Publicado: (2021)

Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran
por: Moradi, Nasrin, et al.
Publicado: (2022)

Valuation of the EQ-5D-5L in Taiwan
por: Lin, Hsiang-Wen, et al.
Publicado: (2018)

Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients
por: Fitriana, Titi Sahidah, et al.
Publicado: (2021)

Comparison of the EQ-5D-Y-5L, EQ-5D-Y-3L and PedsQL in children and adolescents
por: Verstraete, Janine, et al.
Publicado: (2022)

Anchoring Vignettes in EQ-5D-5L Questionnaire: Validation of a New Instrument
por: Azzolina, Danila, et al.
Publicado: (2017)

Discriminative validity of the EQ-5D-5 L and SF-12 in older adults with arthritis
por: Tawiah, Andrews K., et al.
Publicado: (2019)

Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi
por: Ngwira, Lucky G., et al.
Publicado: (2023)

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
por: Herdman, M., et al.
Publicado: (2011)

Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective
por: Whalley, Diane, et al.
Publicado: (2018)

Validity and analysis of the Diabetes Injection Device Preference Questionnaire (DID-PQ)
por: Boye, Kristina S., et al.
Publicado: (2020)

Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys
por: Martí-Pastor, Marc, et al.
Publicado: (2018)

Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L descriptive systems and utilities in atopic dermatitis
por: Koszorú, Kamilla, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aedhka7q4gs4m8r21ce5tiig6p